Publication

Article

Pharmaceutical Executive

Pharmaceutical Executive: December 2024
Volume44
Issue 12

Pharmaceutical Executive: December 2024 Issue (PDF)

Click the title above for a link to open the Pharmaceutical Executive December 2024 issue in an interactive PDF format.

Download Issue PDF
Articles in this issue
Pharmaceutical Executive: December 2024 Issue (PDF)
Pharmaceutical Executive: December 2024 Issue (PDF)
Trending Forward
Trending Forward
Pharma’s ‘Best-Kept Secret’
Pharma’s ‘Best-Kept Secret’
Seeking More Value, Less Cost
Seeking More Value, Less Cost
Dealmaking Dormant No More
Dealmaking Dormant No More
A Rocky Road for Regulation
A Rocky Road for Regulation

Newsletter

Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.

Subscribe Now!
Related Videos
Related Content
Gilead Subsidiary Kite to Acquire Interius BioTherapeutics for $350 Million
August 23rd 2025

Gilead Subsidiary Kite to Acquire Interius BioTherapeutics for $350 Million

Don Tracy, Associate Editor
The Rx for High-Performance Leadership: Cutting Through the Chaos
August 23rd 2025

The Rx for High-Performance Leadership: Cutting Through the Chaos

Michael Christel
Stock.adobe.com
August 23rd 2025

Lighthouse Pharmaceuticals Awarded $49.2 Million Grant from NIA to Advance Phase 2 study of LHP588

Nicholas Jacobus
Addressing Disparities in Psoriasis Trials: Takeda's Strategies for Inclusivity in Clinical Research
August 23rd 2025

Addressing Disparities in Psoriasis Trials: Takeda's Strategies for Inclusivity in Clinical Research

Miranda Schmalfuhs
© WESTOCK - © WESTOCK - stock.adobe.com
August 23rd 2025

Supreme Court Upholds NIH Funding Cuts Affecting DEI in Clinical Research

Andy Studna
XOMA Royalty Subsidiary to Acquire Mural Oncology in Premium Cash Transaction
August 23rd 2025

XOMA Royalty Subsidiary to Acquire Mural Oncology in Premium Cash Transaction

Don Tracy, Associate Editor